Newswise — Over 12,000 new cases of invasive cervical cancer are diagnosed per year and approximately 4,000 women die from the disease. However, since 1955, the number of deaths from cervical cancer has declined due to enhanced screening methods. That means that while 1 out of 4 women will get the types of human papilloma virus (HPV) which can cause cervical cancer, only 1 out of 1,000 of those women will develop full-blown disease.
Dr. Garth Phibbs, a board-certified obstetrician and gynecologist specializing in gynecological oncology at ProMedica Toledo Hospital is available to answer the following and other questions regarding cervical cancer:
Should you schedule a PAP test or an HPV test?
What is the difference between the PAP and HPV test?
How often should you be tested?
How do you know if you are at risk for developing cervical cancer?
What happens after you have been diagnosed?
What do you need to know about treatment?
ProMedica Toledo Hospital is a member of ProMedica, a mission-based organization that is ranked the No. 2 most integrated health system in the U.S. ProMedica was formed in 1986 and is a Toledo, Ohio-based, not-for-profit healthcare organization with nearly 14,000 employees; 3,000 physicians and more than 306 facilities in Ohio and Michigan. ProMedica serves more than 2.73 million patients annually and includes 11 hospitals; ProMedica Continuum Services with senior, hospice, rehabilitation, and integrative services; ProMedica Physicians, a network of more than 315 primary care and specialty physicians; and Paramount Health Care, the largest HMO in northwest Ohio. For more information, please visit www.promedica.org.
RSS